Articles by Hallie Forcinio - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Hallie Forcinio

New Systems for Counterfeit Protection and Quality Control

Counterfeiting prevention has joined quality control as a top concern for pharmaceutical manufacturers. Both issues received a high level of attention at the recent Interphex and Interpack trade exhibitions.
Jun 2, 2005

Most experts recommend layering protective technologies by selecting a combination of overt and covert techniques.

Bar Coding Deadline Looms

May 2, 2005

The unit-dose bar coding rule requires integrating many aspects of packaging design and control.

Cold Chain Concerns

Apr 2, 2005

RFID and battery-powered containers are among the developments receiving attention in the pharmaceutical cold chain.

Can Inserts Be Improved?

Oct 2, 2004

Stakeholders consider ways to improve printed patient inserts.

Particulate-Free Pallets

Sep 2, 2004

Particulate generation and durability concerns are encouraging pharmaceutical manufacturers to seek alternatives to wood pallets.

Interphex Delivers Packaging Solutions

Aug 2, 2004

This month's column highlights some of the latest innovations in packaging seen at this year's Interphex conference.

Research Tips To Find Packaging Facts Fast

Jun 2, 2004

Comprehensive Web sites, journals, and other sources help pharmaceutical makers find packaging-related data quickly and easily.

Prepare for Bar Coding

May 2, 2004

Drug makers and their suppliers will need good planning and organization to meet the new bar coding requirements for drug products used in hospitals.

Packaging Helps Protect Temperature-Sensitive Products

Mar 2, 2004

Protecting a product from temperature abuse is gaining importance as regulators seek proof of product stability throughout the distribution process.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here